Exclusive

Publication

Byline

NHA penalises 2,842 hospitals, blocks Rs.678 cr bogus claims under Ayushman Bharat

New Delhi, July 19 -- The National Health Authority (NHA) has taken strict action against 2,842 hospitals for fraudulent practices under the government's flagship public health insurance scheme, impos... Read More


NHA penalizes 2,842 hospitals, blocks Rs.678 cr bogus claims under Ayushman Bharat

New Delhi, July 19 -- The National Health Authority (NHA) has taken strict action against 2,842 hospitals for fraudulent practices under the government's flagship public health insurance scheme, impos... Read More


Mint Explainer | Why India is introducing uniform digital codes for medical laboratories

New Delhi, July 17 -- India is trying to fix a basic problem holding back its digital health ambitions: the same medical test can be recorded under different names by different laboratories. The Mini... Read More


India bets Rs.10,000 cr on a generics to biologics leap

New Delhi, July 17 -- India is preparing to spend Rs.10,000 crore to build a capability its pharmaceutical industry still lacks: discovering, testing and scaling complex biological medicines. The gove... Read More


Drone use to ferry samples slashes TB diagnosis cost, time: ICMR

New Delhi, July 16 -- Using drones to transport sputum samples for tuberculosis (TB) tests can dramatically reduce both the cost and time involved in diagnosis, according to an Indian Council of Medic... Read More


India bets Rs.10,000 crore on a leap from generic drugs to biologics

New Delhi, July 16 -- India is preparing to spend Rs.10,000 crore to build a capability its pharmaceutical industry still lacks: discovering, testing and scaling complex biological medicines. The gov... Read More


Drugmakers ready response as regulator targets brand name extensions

New Delhi, July 15 -- India's pharmaceutical industry is collating product data to mount a response to the government's notice on drug brand name extensions. To compile the database, pharma associati... Read More


Drug lab rejects Bio-Med rabies vaccine batch over quality issues

New Delhi, July 14 -- New Delhi: India's central drug testing laboratory has declared a batch of Bio-Med Pvt. Ltd's human rabies vaccine "not of standard quality" after it failed key safety tests, acc... Read More


Oxford begins first human trial of Bundibugyo Ebola vaccine

New Delhi, July 13 -- The Oxford Vaccine Group has begun the world's first Phase I clinical trial of a vaccine against the Bundibugyo strain of the Ebola virus, according to a joint statement issued b... Read More


Hips don't lie: India to ditch BMI, track waist-to-hip ratio to fight obesity

New Delhi, July 13 -- India plans to introduce waist-to-hip ratio (WHR) tracking across public hospitals as part of a nationwide strategy to curb obesity, marking a shift away from relying primarily o... Read More